Fiche centre
Addenbrookes Hospital
Cambridge — United Kingdom
Essais liés5clinical trials
VilleCambridgelocalisation
PaysUnited Kingdomlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07913919
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Anifrolumab | Lupus | Non applicable | NCT07913919 | AISLE — Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus Study | RECRUITING |
| Vagus Nerve Stimulation (VNS) Therapy | SEP | Phase 4 | NCT01118455 | Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory Seizures | TERMINATED |
| Nipocalimab | Lupus | Phase 3 | NCT07438496 | GARDENIA-SLE — A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | RECRUITING |
| Obecabtagene autoleucel (obe-cel) | Lupus | Phase 1 | NCT06333483 | CARLYSLE — Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING |
| Inebilizumab | Lupus | Phase 2 | NCT06570798 | A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases | RECRUITING |